Target Name: MIR3617
NCBI ID: G100500897
Review Report on MIR3617 Target / Biomarker Content of Review Report on MIR3617 Target / Biomarker
MIR3617
Other Name(s): microRNA 3617 | hsa-miR-3617-5p | MicroRNA 3617 | hsa-mir-3617 | hsa-miR-3617-3p

MIR3617: A Drug Target / Disease Biomarker

MIR3617 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and lungs. It is a key regulator of cell growth and differentiation, and has been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a drug target, MIR3617 is being targeted by researchers to develop new treatments for these diseases.

One of the reasons why MIR3617 is being targeted as a drug target is its role in cancer. Cancer is a leading cause of death around the world, and there is a strong need for new treatments to address the growing number of cases. MIR3617 has been shown to be involved in the regulation of cell growth and differentiation, which are key factors in the development and progression of cancer. By targeting MIR3617 with drugs, researchers hope to inhibit its activity and prevent the growth and spread of cancer cells.

Another area where MIR3617 is being targeted as a drug target is its role in neurodegenerative diseases. Neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, are progressive and terminal conditions that affect the brain and nervous system. There is currently no cure for these diseases, and there is a strong need for new treatments to slow their progression and improve quality of life. MIR3617 has been shown to be involved in the regulation of cell growth and differentiation, which may be a key factor in the development and progression of these diseases. By targeting MIR3617 with drugs, researchers hope to inhibit its activity and slow the progression of neurodegenerative diseases.

In addition to its role in cancer and neurodegenerative diseases, MIR3617 is also being targeted as a drug target for autoimmune disorders. Autoimmune disorders, such as rheumatoid arthritis, lupus, and multiple sclerosis, are chronic and often painful conditions that affect the immune system. There is currently no cure for these disorders, and they can significantly impact a person's quality of life. MIR3617 has been shown to be involved in the regulation of cell growth and differentiation, which may be a key factor in the development and progression of autoimmune disorders. By targeting MIR3617 with drugs, researchers hope to inhibit its activity and improve the treatment outcomes for autoimmune disorders.

In conclusion, MIR3617 is a protein that is being targeted as a drug target due to its role in cancer, neurodegenerative diseases, and autoimmune disorders. Researchers are hoping to develop new treatments for these diseases by inhibiting MIR3617's activity with drugs. As more research is conducted on MIR3617, it is clear that this protein is an attractive target for the development of new treatments for a variety of diseases.

Protein Name: MicroRNA 3617

The "MIR3617 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR3617 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR3618 | MIR3619 | MIR362 | MIR3620 | MIR3621 | MIR3622A | MIR3622B | MIR363 | MIR3646 | MIR3648-1 | MIR3649 | MIR3650 | MIR3651 | MIR3652 | MIR3654 | MIR3655 | MIR3658 | MIR3659 | MIR365A | MIR365B | MIR3660 | MIR3661 | MIR3662 | MIR3663 | MIR3664 | MIR3665 | MIR3667 | MIR3667HG | MIR3668 | MIR367 | MIR3670-1 | MIR3670-2 | MIR3671 | MIR3672 | MIR3674 | MIR3675 | MIR3677 | MIR3678 | MIR3679 | MIR3680-1 | MIR3680-2 | MIR3681 | MIR3681HG | MIR3682 | MIR3683 | MIR3685 | MIR3686 | MIR3687 | MIR3688-1 | MIR3688-2 | MIR3689A | MIR3689B | MIR3689C | MIR3689D1 | MIR3689D2 | MIR3689F | MIR369 | MIR3690 | MIR3691 | MIR3692 | MIR370 | MIR3713 | MIR3714 | MIR371A | MIR371B | MIR372 | MIR373 | MIR374A | MIR374B | MIR374C | MIR375 | MIR376A1 | MIR376A2 | MIR376B | MIR376C | MIR377 | MIR378A | MIR378B | MIR378C | MIR378D1 | MIR378D2 | MIR378E | MIR378F | MIR378G | MIR378H | MIR378I | MIR379 | MIR380 | MIR381 | MIR382 | MIR383 | MIR384 | MIR3907 | MIR3908 | MIR3909 | MIR3910-1 | MIR3910-2 | MIR3911 | MIR3912 | MIR3913-1